Vaccines for the world’s most deadly diseases, like cancer and heart disease, will likely be ready by 2030 and could save millions of lives, according to the top doctor at one the world’s leading drug companies. The announcement is yet another sign of what many are calling “the golden age” […]
Read More
This may be one of the last few summers that people will need to mostly depend on doing tick checks as the best defense against getting Lyme disease. Multiple drugmakers are developing vaccines that could help people avoid the many troubling symptoms of the tick-borne illness. Earlier this month, Moderna […]
Read More
La inmunidad proporcionada por una infección por SARS-CoV-2 protege a una persona contra una enfermedad grave al igual que 2 dosis de la vacuna de ácido ribonucleico mensajero (ARNm), según un nuevo estudio. Las personas que se infectaron con SARS-CoV-2 redujeron sus posibilidades de hospitalización y muerte en 88% durante 10 […]
Read More
Con motivo de la presentación de resultados del segundo trimestre del año, la farmacéutica Moderna, Inc. ha actualizado la situación de las vacunas en su pipeline. Respecto a las respiratorias, y al margen de las del COVID-19 (destacan la fase II de una vacuna de mRNA que no precisa de […]
Read More
U.S. Food and Drug Administration advisers say Moderna’s COVID-19 vaccine is safe and effective for children aged 6 months to 17 years, according to an FDA document made public on Friday. Two doses of the Moderna vaccine caused an immune response in clinical trial participants that was similar to the immune response […]
Read More
Americans who have received a COVID-19 booster shot are 97 times less likely to die from the coronavirus than those who aren’t vaccinated, according to a new update from the CDC. In addition, fully vaccinated Americans — meaning those with up to two doses, but no booster — are 14 […]
Read More
Moderna on Wednesday released interim results indicating that its mRNA-1273 COVID vaccine produced “robust” neutralizing antibody titers in children aged 6 months to 6 years — levels similar to those seen in adults. Vaccine efficacy against infection was 43.7% in children aged 6 months to 2 years and 37.5% among […]
Read More
Moderna and Pfizer are seeking FDA approval for second COVID-19 booster shots. On Thursday, Moderna formally requested the FDA grant emergency authorization for a second booster shot of its COVID-19 vaccine for all adults over 18 who’ve received approved vaccines. Earlier this week, on Tuesday, Pfizer and its partner BioNTech […]
Read More
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for use of Moderna’s vaccine for people ages 18 years and older. This recommendation follows FDA’s decision earlier this weekexternal icon to approve the Moderna COVID-19 Vaccine for people ages 18 years and older. […]
Read More
Human clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week. The first vaccinations were given Thursday at George Washington University School of Medicine and Health Sciences in Washington, DC, the company said […]
Read More